Skip to content

Search

Showing results for "early lung health"

Be involved

Find out how to participate in our research and community groups.

CliniKids and Griffith University partner for autism research

The Kids Research Institute Australia’s CliniKids and Griffith University are excited to announce a new partnership which will help to grow autism research in Australia.

Screen time study reveals kids missing out on language development

Toddlers exposed to screen time at home are hearing fewer words and making fewer vocalisations, findings from the first longitudinal study to measure the relationship between family screen use and children’s language development have shown.

Twenty-Five Year Survival of Children with Intellectual Disability in Western Australia

To investigate survival up to early adulthood for children with intellectual disability and compare their risk of mortality with that of children without intellectual disability.

Pandemic clinical case definitions are non-specific

During the early phases of the 2009 pandemic, subjects with influenza-like illness only had laboratory testing specific for the new A(H1N1)pdm09 virus.

Autism Research

The Kids' autism research takes place at CliniKids, a centre that integrates world-class research with a clinical service for children with developmental delay and/or autism and their families.

Indigenous researcher awarded prestigious Forrest Fellowship

Outstanding Aboriginal researcher Jessica Buck has received a prestigious Forrest Foundation Research Fellowship to investigate innovative new therapies for children with brain cancer.

InFocus Interview: Kirsten Hancock on multigenerational disadvantage in Australia

An InFocus Research Interview with Kirsten Hancock of the Human Capability Team at The Kids Research Institute Australia on multigenerational disadvantage in Australia.

The Kids Research Institute Australia researcher awarded prestigious Eureka award

Professor Andrew Whitehouse awarded the most prestigious award in the country for young researchers – the 3M Eureka Prize for Emerging Leader in Science.

Clinical Trials

We are in a new era of T1D care. We can now identify and provide care for people across a spectrum of T1D, from early-stage T1D to symptomatic insulin requiring T1D (Stage 3 and Stage 4). And for the first time since the discovery of insulin over 100 years ago, Australia has approved a new therapy, Teplizumab.